ATLANTA, Nov. 1, 2016 /PRNewswire/ -- ResMed (NYSE:RMD)
today introduced the AirFit N20 nasal mask and AirFit F20 full face
mask for positive airway pressure (PAP) treatment of sleep apnea.
Loaded with innovations designed to improve mask fit, comfort and
ease of use, the new-generation ResMed masks are the result of more
than three years of research and development.
The AirFit N20 and AirFit F20 feature ResMed's innovative new
InfinitySeal silicone cushion that adapts to the unique facial
contours of each patient to increase comfort, improve fit and
reduce leakage for maximum treatment efficacy. Hard-to-fit masks
affect sleep specialists and patients alike, so with the new AirFit
20 series, ResMed has taken one of its most popular mask features –
magnetic clips, which make the headgear easier to get on and off –
and introduced them on its full face model.
Testing shows the AirFit N20 fit an astonishing 99 percent of
patients tested, and the AirFit F20 fit an impressive 97 percent –
regardless of facial structure, gender or age.1–5
"These new masks address two of the biggest catalysts for
effective sleep apnea treatment: fit and comfort," said ResMed CEO
Mick Farrell. "Patients rate mask
comfort as the number one reason that can help them stay on
therapy. Not only are the F20 and N20 our most comfortable masks
ever, they're easier and faster for clinicians to fit on patients
the first time, helping more people suffering from sleep apnea
adhere to this life-changing therapy."
The masks are part of ResMed's Air Solutions connected care
portfolio, complementing its best-selling, cloud-enabled
Air10TM flow generator devices and myAirTM
and AirViewTM monitoring tools that are proven to help
improve patients' CPAP use.
Availability
The new ResMed AirFit 20 masks will be
shown publicly for the first time in the U.S. at the Medtrade Fall
medical industry conference in Atlanta, October 31–November 3, 2016. Visit
ResMed's Booth #1511.
ResMed plans to make the AirFit F20 and AirFit N20 available in
the U.S. this quarter. The launch is subject to clearance by the
U.S. Food and Drug Administration. Both masks are currently being
rolled out in EMEA and Asia-Pacific.
About ResMed
ResMed (NYSE:RMD) changes lives with
award-winning medical devices and cutting-edge cloud-based software
applications that better diagnose, treat and manage sleep apnea,
chronic obstructive pulmonary disease (COPD) and other chronic
diseases. ResMed is a global leader in connected care, with more
than 2 million patients remotely monitored every day. Our
5,000-strong team is committed to creating the world's best
tech-driven medical device company – improving quality of life,
reducing the impact of chronic disease, and saving healthcare costs
in more than 100 countries.
ResMed.com | Facebook | Twitter | LinkedIn
- ResMed internal study of 22 existing ResMed patients, conducted
between April 26–May 27, 2016, comparing the market-leading mask
with AirFit F20. Preliminary patient study – data on file; ID
A3810791.
- ResMed AirFit F20 internal fitting study of 27 ResMed and
non-ResMed patients, conducted between March 30–April 04, 2016.
Preliminary patient study – data on file; ID A3751086.
- ResMed AirFit F20 internal international fitting study of 34
ResMed and non-ResMed patients, conducted between April 11–15,
2016. Preliminary patient study – data on file; ID A3774922.
- ResMed AirFit F20 internal international fitting study of 90
ResMed and non-ResMed patients, conducted between June 6–22, 2016.
Preliminary patient study – data on file; ID A3830701
- ResMed AirFit N20 internal global fitting study of 159 existing
ResMed patients, conducted November 12,
2015; ID A3697629.
Contacts:
|
|
For News
Media
|
For
Investors
|
Jayme
Rubenstein
|
Agnes Lee
|
Public Relations
Manager
|
Senior Director,
Investor Relations
|
O:
858-836-6798
|
O:
858-836-5971
|
news@resmed.com
|
investorrelations@resmed.com
|
|
|
Logo -
http://photos.prnewswire.com/prnh/20140310/LA79234LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/resmed-introduces-airfit-n20-and-airfit-f20-cpap-masks-a-new-standard-for-fit-and-comfort-300354561.html
SOURCE ResMed Inc.